Literature DB >> 6542029

Role of the area postrema in vomiting and related functions.

H L Borison, R Borison, L E McCarthy.   

Abstract

Before 1949, the vomiting center was said to be located in the dorsal vagal nuclei of the medulla, but it was uncertain whether two centers existed separately for the control of direct and reflex actions of emetic agents. Borison and Wang then used a stereotaxic technique with electrical stimulation to localize the vomiting center in the reticular formation at a measurable distance from the dorsal vagal nuclei. They also formulated the concept of a separate emetic chemoreceptor trigger zone (CTZ) so that the vomiting center itself is not sensitive to emetic agents and serves solely to coordinate the reflex process. The CTZ was soon identified with the area postrema (AP), but the question remains unanswered whether the CTZ constitutes part or all of tht circumventricular organ. Furthermore, different chemosensory functions, as for defecation and certain forms of autonomic expression, may be represented regionally within the AP. Species that are unable to vomit, e.g., rodents, show other postrema-mediated effects as radiation-induced gastric stasis and drug-induced conditioned taste aversion. In sheep, digitalis-induced arrest of rumination is prevented by postremectomy. It is suggested that these behavioral end points in nonvomiting species may serve for biological assay of antinauseant drugs. Finally, a tabular summary is given of known causes of vomiting in which the AP has been implicated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542029

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  14 in total

1.  Protracted vomiting as the presenting sign of posterior fossa mass lesions.

Authors:  G Torrealba; S Del Villar; P Arriagada
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

2.  A diffusion barrier between the area postrema and nucleus tractus solitarius.

Authors:  Qing-Ping Wang; Jian-Lian Guan; Weihong Pan; Abba J Kastin; Seiji Shioda
Journal:  Neurochem Res       Date:  2008-03-29       Impact factor: 3.996

Review 3.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 4.  Pathophysiology of cytotoxic drug-induced emesis: far from crystal-clear.

Authors:  C Seynaeve; P H De Mulder; J Verweij
Journal:  Pharm Weekbl Sci       Date:  1991-02-22

Review 5.  Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.

Authors:  C Veyrat-Follet; R Farinotti; J L Palmer
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

6.  5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret.

Authors:  G A Higgins; G J Kilpatrick; K T Bunce; B J Jones; M B Tyers
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

Review 7.  Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases.

Authors:  Paul L R Andrews; Charles C Horn
Journal:  Auton Neurosci       Date:  2006-03-23       Impact factor: 3.145

Review 8.  Do conditioned taste aversions result from activation of emetic mechanisms?

Authors:  V L Grant
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 9.  Chemotherapy induced emesis--mechanisms and treatment: a review.

Authors:  C M Edwards
Journal:  J R Soc Med       Date:  1988-11       Impact factor: 18.000

Review 10.  Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors.

Authors:  J K DiBaise; E M Quigley
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.